Compound News and Research

RSS

Sargramostim drug can also improve memory in people with mild-to-moderate Alzheimer's disease

A new study suggests that Sargramostim, a medication often used to boost white blood cells after cancer treatments, is also effective in treating and improving memory in people with mild-to-moderate Alzheimer's disease.

24 Mar 2021

New covalent and non-covalent SARS-CoV-2 inhibitors discovered in silico

A new study describes the use of a combination of virtual and experimental screening protocols to identify potential inhibitors of the virus, which could lead to rapid drug development.

24 Mar 2021

Dandelion extract inhibits SARS-CoV-2 in vitro

An exciting new study describes a specific inhibitor of the SARS-CoV-2 found in an extract of the common dandelion that could provide a new and fruitful avenue of drug research.

23 Mar 2021

A green tea compound shows anti-SARS-CoV-2 properties in vitro

Researchers show the antiviral potential of a green tea compound against SARS-CoV-2 infection.

22 Mar 2021

VHIO-born spin-off receives approval to initiate Phase I/II clinical trial of novel Myc inhibitor

Co-founded back in 2014 by VHIO's Laura Soucek, CEO of the enterprise, and Marie-Eve Beaulieu, Chief Scientific Officer (CSO) of the company, VHIO-born spin-off Peptomyc S.L. has just announced that it has received approval from the Spanish Agency of Medicines and Medical Devices for conducting clinical trials in Spain (AEMPS), to initiate the first-in-human Phase I/II clinical trial with its first compound - a disruptive Myc inhibitor, Omomyc (OMO-103).

19 Mar 2021

New antibiotic compound can effectively clear multi-drug resistant gonorrhea in animals

A new antibiotic compound clears infection of multi-drug resistant gonorrhea in mice in a single oral dose, according to a new study led by researchers at Penn State and Emory University.

19 Mar 2021

Anti-SARS-CoV-2 drug candidate enters phase I clinical trial

DC402234 (FB2001), an anti-SARS-CoV-2 drug candidate mainly developed by research team at the Shanghai Institute of Materia Medica (SIMM) of Chinese Academy of Sciences enters its Phase I clinical trial in the United States on March 15.

19 Mar 2021

Do Artemisia annua L. compounds have SARS-CoV-2 antiviral potential?

Caused by SARS-CoV-2, the ongoing COVID-19 pandemic has led to over 121.2 million cases and over 2.6 million deaths worldwide. An interesting new study examines the potential antiviral activity of compounds present in the plant Artemisia annua L.

18 Mar 2021

Insights into elusive protein complex can help find novel treatments for chromosomal disorders

The cells in our body are constantly fighting off the threat of cancer by repairing damaged DNA. In a new study, scientists from Tokyo University of Science investigate the structure of an elusive protein complex that plays a key role in the activation of the "Fanconi anemia pathway" involved in DNA repair, and report on the factors governing its stability.

17 Mar 2021

INTEGRA’s VOYAGER adjustable tip spacing pipettes streamline the production of venom-based screening assays

Venomtech® – a leading UK-based biotechnology company founded in 2010 – is harnessing the power of natural venoms produced by animals to generate compound libraries that are used in drug discovery studies.

From INTEGRA Biosciences 17 Mar 2021

CAS Common Chemistry now provides authoritative data on almost 500,000 substances

CAS, a division of the American Chemical Society (ACS) that specializes in scientific information solutions, has expanded the CAS Common Chemistry resource.

17 Mar 2021

Cannabis compound inhibits SARS-CoV-2 replication in human lung cells

Researchers in the United States have conducted a study showing that a cannabis plant compound inhibited infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human lung cells.

14 Mar 2021

Novel CRISPR-based gene editor developed to correct mutations that cause genetic disorders

A team of researchers from the Agency for Science, Technology and Research's (A*STAR) Genome Institute of Singapore have developed a CRISPR-based gene editor, C-to-G Base Editor (CGBE), to correct mutations that cause genetic disorders.

11 Mar 2021

Researchers discover new molecular target that could treat idiopathic pulmonary fibrosis

Researchers at the University of Alabama at Birmingham have identified a new molecular target that could potentially treat the deadly, aging-related lung disease idiopathic pulmonary fibrosis (IPF).

10 Mar 2021

NTU scientists design new compound that could help reduce overactive immune response

When the body detects a pathogen, such as bacteria or viruses, it mounts an immune system response to fight this invader. In some people, the immune system overreacts, resulting in an overactive immune response that causes the body to injure itself, which may prove fatal in some cases.

10 Mar 2021

Compound News and Research

Sargramostim drug can also improve memory in people with mild-to-moderate Alzheimer's disease

New covalent and non-covalent SARS-CoV-2 inhibitors discovered in silico

Dandelion extract inhibits SARS-CoV-2 in vitro

A green tea compound shows anti-SARS-CoV-2 properties in vitro

VHIO-born spin-off receives approval to initiate Phase I/II clinical trial of novel Myc inhibitor

New antibiotic compound can effectively clear multi-drug resistant gonorrhea in animals

Anti-SARS-CoV-2 drug candidate enters phase I clinical trial

Do Artemisia annua L. compounds have SARS-CoV-2 antiviral potential?

Insights into elusive protein complex can help find novel treatments for chromosomal disorders

INTEGRA’s VOYAGER adjustable tip spacing pipettes streamline the production of venom-based screening assays

CAS Common Chemistry now provides authoritative data on almost 500,000 substances

Cannabis compound inhibits SARS-CoV-2 replication in human lung cells

Novel CRISPR-based gene editor developed to correct mutations that cause genetic disorders

Researchers discover new molecular target that could treat idiopathic pulmonary fibrosis

NTU scientists design new compound that could help reduce overactive immune response

Discover, Visualize and Identify Biomarkers

Researchers confirm new drug development route for treating multiple sclerosis, asthma

New compound can reduce overactivation without impairing the body's immunity response

Researchers investigate compound effects of pandemics/natural disasters on health care systems

Human cerebral organoid model to screen drugs for treatment of Creutzfeldt-Jakob disease

Advancing therapeutic biopolymer development eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News